These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1676170)

  • 1. Latent inhibition is unaffected by direct dopamine agonists.
    Feldon J; Shofel A; Weiner I
    Pharmacol Biochem Behav; 1991 Feb; 38(2):309-14. PubMed ID: 1676170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential stimulation of D1 or D2 receptors disrupts food-rewarded operant responding in rats.
    Hoffman DC; Beninger RJ
    Pharmacol Biochem Behav; 1989 Dec; 34(4):923-5. PubMed ID: 2576145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
    Cory-Slechta DA; Pokora MJ; Widzowski DV
    Brain Res; 1992 Dec; 598(1-2):162-72. PubMed ID: 1362517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
    Williams JE; Woolverton WL
    Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
    Cory-Slechta DA; Widzowski DV
    Brain Res; 1991 Jul; 553(1):65-74. PubMed ID: 1681979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I; Bryer JB; Starkstein SE; Honig M; Moran TH; Robinson RG
    Brain Res; 1990 Nov; 533(2):286-91. PubMed ID: 1981170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH; Fechtali T; Rostain JC
    Neuroscience; 1992 Sep; 50(2):395-402. PubMed ID: 1359460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning.
    Hoffman DC; Beninger RJ
    Pharmacol Biochem Behav; 1988 Sep; 31(1):1-8. PubMed ID: 2908061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor subtypes and formalin test analgesia.
    Morgan MJ; Franklin KB
    Pharmacol Biochem Behav; 1991 Oct; 40(2):317-22. PubMed ID: 1687167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus.
    Imperato A; Obinu MC; Gessa GL
    Brain Res; 1993 Aug; 618(2):341-5. PubMed ID: 8104086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic effect of locally applied apomorphine and 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine on the release of striatal dopamine investigated by means of brain dialysis.
    Kurata K; Shibata R
    Neurosci Lett; 1990 Sep; 117(3):264-8. PubMed ID: 1982738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization and conditioned rotation: apomorphine, quinpirole and SKF-38393 compared.
    Silverman PB
    Neuroreport; 1991 Nov; 2(11):669-72. PubMed ID: 1810459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.